Veeva (VEEV stock) Exceptional Business! SaaS Growth Stock for Life Sciences Industry!

preview_player
Показать описание
Veeva Systems or VEEV stock, is an exceptional business as the leading provider of CRM and other cloud solutions to the life sciences industry. They have a long history of hyper growth & profitability but at what price is too much? Will management be able to reaccelerate the growth rate from here?

.....

If you're ready to take charge of your financial journey, check out:

💡UNRIVALED INVESTING MEMBERSHIP includes frequent letters with new stock ideas, stock market commentary, real-time portfolio updates, and a community of likeminded investors on Discord (for annual subscribers only).

🐦 Twitter: @UnrivaledInvest

....

📽️ Have a priority video request?

.....

📈: Which investment brokerage do I use to buy and sell investments?

DISCLAIMER:
This video is purely for informational and educational purposes. This is NOT investment advice. You should not treat any opinion expressed by Daniel or Unrivaled Investing as a specific inducement to make a particular investment or follow a particular strategy but only as an expression of opinion. Daniel and Unrivaled Investing are not under any obligation to update or correct any information provided on this website or in these videos. Daniel and Unrivaled Investing’s statements and opinions are subject to change without notice.

You should be aware of the real risk of loss in following any strategy or investment discussed in this video or on this website. Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned by Daniel or Unrivaled Investing may not be suitable for you. Past performance is not indicative of future results.

At the time of this publication, Daniel owned shares in C3.AI (AI stock) and Alphabet (GOOG).

INTERACTIVE BROKERS DISCLAIMER:

None of the information contained herein constitutes a recommendation, offer, or solicitation of an offer by Interactive Brokers to buy, sell or hold any security, financial product or instrument or to engage in any specific investment strategy. Investment involves risks. Investors should obtain
their own independent financial advice and understand the risks associated with investment products/ services before making investment decisions. Risk disclosure statements can be found on the Interactive Brokers website.

UNRIVALED INVESTING is a customer of Interactive Brokers. Interactive Brokers and UNRIVALED INVESTING have entered into a cost-per-click agreement under which Interactive pays Daniel a fee for each click-through of the Interactive Brokers URL posted herein.
Рекомендации по теме
Комментарии
Автор

Take charge of your financial journey with expert investment insights, stock ideas and market commentary at www.unrivaledinvesting.com! Thank you to all the UNRIVALED INVESTING subscribers that keep this channel going!

unrivaled
Автор

Finally D brings us a winner! Not sure how this company isn't more well known.

michaelfriend
Автор

Great Analysis! Potential yellow- or even red flag on valuation, I agree. However I think this may be a long term winner because TAM is not just the medical industry but also other industries heavy on regulations (beauty- and skinn care products, chemicals, etc). Veeva is potentially a "hidden monopoly" in a potentially very large and growing TAM - the kind of business you tend to find too expensive, but also the kind you keep regretting not getting in on "years ago".

larse
Автор

Great video: good research, great insights, super helpful valuation analysis at the end! Keep up the good work 👍

vladpuescu
Автор

Hey Daniel, great video. I already have a position in ABCL which is a company that was using data and AI to help Pharma companies develop vaccines and drugs. I thought they are the only one doing this but VEEV seems to have similar capabilities. Check out ABCL and let me know what u think of they compare.

eskKyle
Автор

I would love to hear your opinion on OLED Stock (Universal display)

arthurfarber
Автор

11:10 Peter Gassner worked at Salesforce and is very good friends with Marc Benioff. Not worried about that risk.

AC-getr
Автор

26 billion?! thats NUTS!!!! What upside are people playing for here?!

FKAS
Автор

Great video just what I needed now that VEEV price fell a lot but still overvalued.

panamahub
Автор

I held this stock and made great returns. Thankfully sold it before its decline.

Viperever
Автор

Can you do video for UIpath after results ?

mariyanstoyanov
Автор

I thought you would do UiPath video first right after its earnings 🤔

OsiyoFotimaMaryam
Автор

I've seen some of your videos and I'm interested in trying out your quarterly service. Any trials or special offers available? Thanks.

johankirsten
Автор

Nongaap has very little value to me. Everyone looks good with nongaap. I mean they literally created it for that reason.

davidkoba